Gao Xiujuan, Xu Junqing, Xu Zengqiang, Jiang Mengxin, Zhu Jiahao, Geng Yang, Dong Shengjun, Li Yanuo, Zhou Zhengtong, Xu Yingjiang
Binzhou Medical University Hospital, Binzhou City, PR China.
The First School of Clinical Medicine, Binzhou Medical University, Binzhou City, PR China.
Cell Death Discov. 2025 Aug 22;11(1):396. doi: 10.1038/s41420-025-02697-1.
The liver-adipose axis represents a crucial regulatory network that governs systemic lipid homeostasis, with signals originating from the liver orchestrating the plasticity of adipose tissue through diverse mechanisms. A comprehensive understanding of these bidirectional communication pathways may uncover novel therapeutic approaches for metabolic disorders. Our research demonstrates that exposure to cold stimulates the liver to secrete exosomes, which enhance thermogenic activation in adipose tissue, as observed in both in vitro and in vivo models. This enhancement of thermogenesis is mechanistically associated with the cold-induced upregulation of hepatocyte-derived exosomal miR-293-5p. Importantly, the pharmacological administration of a miR-293-5p agomir significantly mitigates diet-induced obesity and related metabolic dysfunctions in murine models. Through mechanistic analysis, we identified Tet1 as a direct downstream target of miR-293-5p, noting that the ectopic expression of Tet1 disrupts the thermogenic programming of brown adipose tissue (BAT) independently of miR-293-5p modulation. Our findings establish cold-activated hepatocyte exosomes as endocrine signaling mediators that carry thermogenic microRNA cargos, with miR-293-5p emerging as a key regulator.
肝-脂肪轴代表一个关键的调节网络,该网络控制着全身脂质稳态,源自肝脏的信号通过多种机制协调脂肪组织的可塑性。全面了解这些双向通信途径可能会揭示代谢紊乱的新治疗方法。我们的研究表明,在体外和体内模型中均观察到,暴露于寒冷环境会刺激肝脏分泌外泌体,从而增强脂肪组织中的产热激活。这种产热增强在机制上与冷诱导的肝细胞来源的外泌体miR-293-5p上调有关。重要的是,在小鼠模型中,miR-293-5p激动剂的药物给药显著减轻了饮食诱导的肥胖和相关代谢功能障碍。通过机制分析,我们确定Tet1是miR-293-5p的直接下游靶点,并指出Tet1的异位表达独立于miR-293-5p调节而破坏棕色脂肪组织(BAT)的产热程序。我们的研究结果表明,冷激活的肝细胞外泌体作为携带产热微小RNA货物的内分泌信号介质,miR-293-5p成为关键调节因子。
Int J Mol Sci. 2025-6-23
J Neuroinflammation. 2025-8-4
Diabetes. 2024-2-1
Adv Sci (Weinh). 2021-8
Nat Rev Genet. 2021-1
Nat Commun. 2020-8-27
Proc Natl Acad Sci U S A. 2020-8-24